Skip to main content
Explore URMC

URMC Logo

menu

Douglas P. Rosenzweig, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 275-5261

Office: (585) 275-9969

Fax: (585) 275-1531

Biography

Professional Background

Dr. Rosenzweig is the Acting Director of Medical Physics in the Department of Radiation Oncology at the University of Rochester Medical Center. He entered the field in 1993 as a post-doctoral fellow in the same department, having completed his graduate research in the area of experimental nuclear physics at the University of Washington in Seattle.

A native of Wisconsin, Dr. Rosenzweig served as a senior staff physicist for 8 years at St. Luke's Medical Center in his hometown of Milwaukee. He then took the opportunity to rejoin colleagues here at the URMC in a leadership position as the department undertook the major initiative of relocating to the new Wilmot Cancer Center in 2008. He is currently Acting Director overseeing the Physicist and Dosimetrist activities at the Wilmot Cancer Center and its affiliates. Oversight consists of clinical operations related to quality assurance of linear accelerators, CT's, treatment planning equipment, chart QA and all aspects of brachytherapy.

His main area of interest is external beam radiation therapy.

Credentials

Faculty Appointments

Education

1984
Bachelor of Science | University of Wisconsin

1986
Master of Science | University of Washington

1993
Doctor of Philosophy | University of Washington

Publications

Journal Articles

5/13/2014
Bates JE, Peterson CR, Yeaney GA, Walter KA, Lundquist T, Rosenzweig D, Milano MT. "Spinal drop metastasis in myxopapillary ependymoma: a case report and a review of treatment options." Rare tumors. 2014 May 13; 6(2):5404. Epub 2014 Jun 16.

2003
Rosenzweig, DP. "Every patient receiving 3D or IMRT must have image-based target localization prior to turning on the beam. Against the proposition." Medical Physics. 2003; 30(3): 288-9.

1/2000
Rosenzweig DP, Schell MC, Yu Y. "Toward a statistically relevant calibration end point for prostate seed implants." Medical physics.. 2000 Jan 0; 27(1):144-50.

VIEW ALL PUBLICATIONS